Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akhurst T, Downey RJ, Ginsberg MS et al (2002) An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer. Ann Thorac Surg 73:259–266
Antoch G, Stattaus J, Nemat AT et al (2003a) Non-small cell lung cancer: dual modality PET/CT in preoperative staging. Radiology 229:526–533
Antoch G, Vogt FM, Freudenberg LS et al (2003b) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206
Bar-Shalom R, Yefremov N, Guralnik L et al (2003) Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44:1200–1209
Beyer T, Townsend DW, Brun T et al (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379
Burger C, Goerres G, Schoenes S, Buck A, Lonn AHR, von Schulthess GK (2002) PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med 29:922–927
Chisin R, Pietrzyk U, Sichel JY et al (1993) Registration and display of multimodal images: applications in the extracranial head and neck region. J Otolaryngol 22:214–219
De Bree R, Deurloo EE, Snow GB, Leemans CR (2000) Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110:397–401
Dizendorf EV, Treyer V, von Schulthess GK, Hany TF (2002) Application of oral contrast media in co-registrated positron emission tomography-CT. Am J Roentgenol 179:477–481
Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C (2003) Cause and magnitude of the error induced by oral CT contrast agent in CT-based attenuation correction of PET emission studies. J Nucl Med 44:732–738
Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL (1999) Metastases from non-small cell lung cancer: mediastinal staging in the 1990s — meta-analytic comparison of PET and CT. Radiology 213:530–536
Erasmus JJ, Patz EF, McAdams HP et al (1997) Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. AJR 168:1357–1362
Giraud P, Grahek D, Montravers F et al (2001) CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers. Int J Radiat Oncol Biol Phys 49:1249–1257
Goerres GW, Kamel E, Heidelberg TN et al (2002a) PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med 29:351–60
Goerres GW, Hany TF, Kamel E, von Schulthess GK, Buck A (2002b) Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med 29:367–370
Goerres GW, Stoeckli SJ, von Schulthess GK, Steinert HC (2002c) FDG PET for mucosal malignant melanoma of the head and neck. Laryngoscope 112:381–385
Goerres GW, von Schulthess GK, Hany TF (2002d) Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment. AJR 179:1337–1343
Goerres GW, Schmid DT, Gratz KW, von Schulthess GK, Eyrich GK (2003) Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol 39:547–551
Goerres GW, Schmid DT, Eyrich GK (2004a) Do hardware artifacts influence the performance of head and neck PET scans in patients with oral cavity squamous cell cancer? Dentomaxillofac Radiol 32:365–371
Goerres GW, Schmid DT, Bandhauer F et al (2004b) Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 130:105–109
Goerres GW, von Schulthess GK, Steinert HC (2004c) Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 45[Suppl 1]:66S–71S
Greven KM, Williams DW, Keyes JW et al (1994) Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74:1355–1359
Gupta NC, Maloof J, Gunel E (1996) Probability of malignancy in solitary pulmonary nodules using flurine-18-FDF and PET. J Nucl Med 37:943–948
Hany TF, Steinert HC, Goerres GW, Buck A, von Schulthess GK (2002a) Improvement of diagnostic accuracy of PET imaging using a high performance in-line PET-CT system: preliminary results. Radiology 225:575–581
Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002b) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med 29:1393–1398
Hellwig D, Ukena D, Paulsen F, Bamberg M, Kirsch CM (2001) Metaanalyse zum Stellenwert der Positronen-Emissions-Tomographie mit F-18-Fluorodesoxyglukose (FDG-PET) bei Lungentumoren (in German). Pneumologie 55:367–377
Inoue T, Kim E, Komaki R et al (1995) Detecting recurrent or residual lung cancer with FDG-PET. J Nucl Med 36:788–793
Kamel E, Goerres GW, Burger C, von Schulthess GK, Steinert HC (2002) Detection of recurrent larygeal nerve palsy in patients with lung cancer using PET-CT image fusion. Radiology 224:153–156
Kamel M, Burger C, Buck A, von Schulthess GK, Goerres GW (2003a) Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 13:724–728
Kamel EM, Zwahlen D, Wyss MT et al (2003b) Whole-body 18F-FDG PET improves the management of patients with small-cell lung cancer. J Nucl Med 44:1911–1917
Kernstine KH, McLaughlin KA, Menda Y et al (2002) Can-FDG PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg 73:394–402
Keyes JW Jr, Watson NE Jr, Williams DW 3rd, Greven KM, McGuirt WF. (1997) FDG PET in head and neck cancer. AJR 169:1663–1669
Kinahan PE, Townsend DW, Beyer T, Sashin D (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046–2053
Kitagawa Y, Nishizawa S, Sano K et al (2002) Whole-body (18)F-fluorodeoxyglucose positron emission tomography in patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93:202–207
Kluetz PG, Meltzer CC, Villemagne VL et al (2000) Combined PET/CT Imaging in Oncology. Impact on Patient Management. Clin Positron Imaging 3:223–230
Lardinois D, Weder W, Hany TF et al (2003) Staging of nonsmall-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507
Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204–210
Marom EM, McAdams HP, Erasmus JJ (1999) Staging non-small cell lung cancer with whole-body PET. Radiology 212:803–809
Marom EM, Erasmus JJ, Pass HI, Patz EF Jr (2002) The role of imaging in malignant pleural MPM. Semin Oncol 29:26–35
Mountain CF, Dresler CM (1997) Regional lymph node classification for lung cancer staging. Chest 11:1718–1723
Myers JN, Greenberg JS, Mo V, Roberts D (2001) Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92:3030–3036
Nestle U, Walter K, Schmidt S, Licht N et al (1999) 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. Int J Radiat Oncol Biol Phys 44:593–597
Patterson GA, Ginsberg RJ, Poon PY et al (1987) A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma. J Thorac Cardiovasc Surg 94:679–684
Pieterman RM, van Putten JWG, Meuzelaar JJ et al (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tommography. N Engl J Med 343:254–261
Rendina EA, Bognolo DA, Mineo TC et al (1987) Computed tomography for the evaluation of intrathoracic invasion by lung cancer. J Thorac Cardiovasc Surg 94:57–63
Schneider DB, Clary-Macy C, Challa S et al (2000) Positron emission tomography with F18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural MPM. J Thorac Cardiovasc Surg 120:128–133
Schwartz DL, Rajendran J, Yueh B et al (2003) Staging of head and neck squamous cell cancer with extended-field FDGPET. Arch Otolaryngol Head Neck Surg 129:1173–8
Steinert HC, Hauser M, Allemann F et al (1997) Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202:441–446
Stokkel MP, Moons KG, ten Broek FW, van Rijk PP, Hordijk GJ (1999) 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86:2370–2377
Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnosis of oncological patients. Eur J Nucl Med 23:1409–1414
Vansteenkiste JF, Stroobants SG, De Leyn PR et al (1998) Lymph node staging in non-small cell lung cancer with FDG PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol l16:2142–2149
Weder W, Schmid R, Bruchhaus H, Hillinger S, von Schulthess GK, Steinert HC. (1998) Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 66:886–893
Wong WL, Hussain K, Chevretton E et al (1996) Validation and clinical application of computer-combined computed tomography and positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose head and neck images. Am J Surg 172:628–632
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Steinert, H.C., Goerres, G., von Schulthess, G.K. (2006). PET/CT in Lung, Head and Neck Cancer. In: Baert, A.L., Sartor, K., Schiepers, C. (eds) Diagnostic Nuclear Medicine. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30005-8_12
Download citation
DOI: https://doi.org/10.1007/3-540-30005-8_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-42309-6
Online ISBN: 978-3-540-30005-2
eBook Packages: MedicineMedicine (R0)